目的观察Nano无载体药物支架治疗老年左主干病变的临床疗效。方法选择25例老年左主干病变患者为观察对象,所有患者均植入Nano无载体药物支架治疗,根据患者血管实际情况选用单支架或双支架进行治疗。随访观察患者术后不同时间段的临床疗效。术后12个月对患者进行冠状动脉造影检查,记录患者的心血管事件、血管重建、再狭窄及急性/亚急性血栓形成等情况。结果25例老年左主干病变患者成功植入Nano无载体药物支架35枚,支架长度(20.1±7.6)mm,支架直径(3.5±0.5)mm。植入单支架15例(60.0%);双支架术10例(40.0%),其中Crush Stenting术2例,T-stenting术3例,Culotte Stenting术3例,Simultaneous Kissing Stenting术2例。所有患者经治疗后临床症状均消失,住院及随访期间无死亡,无急性/亚急性血栓及急性心肌梗死发生。结论Nano无载体药物支架可显著提升老年左主干病变疾病患者的预后效果。
ObjectiveTo observe the clinical efficacy of Nano carrier-free drug-coated stent in the treatment of elderly patients with left main coronary artery disease. MethodsTwenty-five elderly patients with left main coronary artery disease were enrolled as objects. All patients were inserted with Nano carrier-free drug-coated stent, and were treated with single-stent or double-stent according to the actual condition of the patient′s vessels. The clinical efficacy of patients was observed at different time points after operation. At 12 months after surgery, coronary angiography was performed in the patients to record the incidence of cardiovascular events, revascularization, restenosis, and acute/subacute thrombosis. ResultsIn the 25 patients, 35 non-carrier drug-coated stents were inserted successfully .The length and diameter of the stents were (20.1±7.6) mm and (3.5±0.5) mm respectively. Single-stent was inserted in 15 cases (60.0%); double-stent was inserted in 10 cases (40.0%) , including 2 cases with Crush Stenting technique, 3 cases with T-stenting technique, 3 cases with Culotte Stenting technique and 2 cases with Simultaneous Kissing Stenting technique. The clinical syndromes disappeared after treatment with Nano carrier-free drug-coated stent in all patients, no death occurred during hospitalization and follow-up, no acute/subacute thrombosis and acute myocardial infarction occurred. ConclusionNano carrier-free drug-coated stent can significantly improve the prognosis and efficacy of elderly patients with left main coronary artery disease.